Watchlist Price Alert

Aardvark Therapeutics Inc... (AARD)

NASDAQ: AARD · Real-Time Price · USD

10.53

-0.32 (-2.95%)

At close: Jun 17, 2025, 1:58 PM

Aardvark Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q4 2023	Q3 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Dec 31, 2023	Sep 30, 2023
Net Income	-24.31M	-17.11M	-8.33M	-4.15M	-2.11M
Depreciation & Amortization	-90K	17K	138K	51K	26K
Stock-Based Compensation	620K	459K	286K	141K	72K
Other Working Capital	-128K	-388K	-10K	-498K	-260K
Other Non-Cash Items	373K	1.11M	930K	839K	742K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.41M	1.1M	282K	378K	-316K
Operating Cash Flow	-24.23M	-14.42M	-6.7M	-2.74M	-1.58M
Capital Expenditures	-11K	-11K	-5K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-124.65M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	12.03M	n/a	n/a	n/a	n/a
Other Investing Acitivies	-11.89M	-11.89M	n/a	n/a	n/a
Investing Cash Flow	-124.52M	-11.9M	-5K	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-3.31M	-1.11M	64K	n/a	n/a
Financial Cash Flow	87.92M	-950K	64K	n/a	n/a
Net Cash Flow	-60.83M	-27.27M	-6.64M	-2.74M	-1.58M
Free Cash Flow	-24.24M	-14.43M	-6.7M	-2.74M	-1.58M